2010
DOI: 10.1016/j.ejca.2009.12.027
|View full text |Cite
|
Sign up to set email alerts
|

VEGF-A promotes lymphoma tumour growth by activation of STAT proteins and inhibition of p27KIP1 via paracrine mechanisms

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
10
0

Year Published

2010
2010
2017
2017

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 14 publications
(11 citation statements)
references
References 34 publications
1
10
0
Order By: Relevance
“…Cyclin-dependent kinase (CDK) inhibitors, including p21, p27 and p15/p15 INK45 , could regulate cell cycles by inhibiting cyclin and CDK activity, thus resulting in G1 arrest. [18][19][20][21][22][23] The activation of PPAR-g could control the cell cycle by regulating p27. The results were confirmed in our study, as 18a-GA decreased cyclin D1 but increased p27 levels.…”
Section: Discussionmentioning
confidence: 99%
“…Cyclin-dependent kinase (CDK) inhibitors, including p21, p27 and p15/p15 INK45 , could regulate cell cycles by inhibiting cyclin and CDK activity, thus resulting in G1 arrest. [18][19][20][21][22][23] The activation of PPAR-g could control the cell cycle by regulating p27. The results were confirmed in our study, as 18a-GA decreased cyclin D1 but increased p27 levels.…”
Section: Discussionmentioning
confidence: 99%
“…Hence, it is possible that ERM-mediated membrane structures regulate tumor microenvironment by providing nutrient/information exchange between cells, as well as secretion of cell survival factors such as cytokines and growth factors. In fact, a high circulating level of vascular endothelial growth factor A (VEGF-A) has been detected in patients with non-Hodgkin’s lymphoma, and tumor cells were identified as the producers of this growth factor in vivo (103). VEGF-A promotes tumor growth by stimulating tumor stromal cells to secret various cytokines including IL-4, IL-6 and IL-10, leading to paracrine activation of tumor cells (103), as well as stimulates cancer cell metastasis by upregulation and activation of ERM family proteins moesin through RhoA/ROCK-2 pathway (104).…”
Section: Erm Proteins In Germinal Center Biologymentioning
confidence: 99%
“…In fact, a high circulating level of vascular endothelial growth factor A (VEGF-A) has been detected in patients with non-Hodgkin’s lymphoma, and tumor cells were identified as the producers of this growth factor in vivo (103). VEGF-A promotes tumor growth by stimulating tumor stromal cells to secret various cytokines including IL-4, IL-6 and IL-10, leading to paracrine activation of tumor cells (103), as well as stimulates cancer cell metastasis by upregulation and activation of ERM family proteins moesin through RhoA/ROCK-2 pathway (104). VEGF is also important for angiogenesis, and hence accelerates metastasis of tumor cells to lymph nodes and distant organs (105).…”
Section: Erm Proteins In Germinal Center Biologymentioning
confidence: 99%
“…However, high vascularity was found in the bone marrow of children with acute lymphoblastic leukemia and a positive correlation between the hemangiogenic protein Vascular Endothelial Growth Factor-A (VEGF-A) and lymphoma progression has been observed [12,13]. Lymphangiogenic growth factors, most importantly VEGF-C and VEGF-D [14-16], increase the number of lymph node metastases of numerous carcinomas [17].…”
Section: Introductionmentioning
confidence: 99%